What insurance policy changes affect CPT 32994?

There are 8 tracked policy changes affecting CPT 32994, including updates from Aetna, Humana, Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 32994?

Payers that have issued tracked updates for CPT 32994 include: Aetna, Humana, Independence Blue Cross.

How do I get notified when CPT 32994 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 32994. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 32994?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

32994 — Your doctor uses extreme cold to destroy a lung tumor through a needle inserted through your skin.: Insurance Policy Changes

32994 Insurance Policy Changes

CPT 32994, in plain terms, covers Your doctor uses extreme cold to destroy a lung tumor through a needle inserted through your skin. CPT 32994 is referenced in 8 tracked payer policy changes from Aetna, Humana, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 32994 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

High impact

Cryoablation (CPB 0100, reviewed 2026-08-04)

Aetna·Effective Aug 4, 2026

Aetna has issued a comprehensive clinical policy bulletin (CPB 0100) establishing medical necessity criteria for cryoablation procedures across multiple anatomical sites and conditions. The policy clearly distinguishes between covered indications (e.g., renal masses up to 4cm, prostate cancer, atrial fibrillation, cervical dysplasia) and experimental/non-covered applications (e.g., breast carcinoma, benign prostatic hypertrophy, osteoarthritis). Billing teams must immediately implement these criteria as authorization rules to ensure claims are processed only when medical necessity requirements are met.

32994 Insurance Policy Changes

Cryoablation (CPB 0100, reviewed 2026-08-04)

Cryoablation - Medicare Advantage (Revised)

MA11.052f, Ablation of Lung Tumors

11.00.16k, Ablation of Lung Tumors

11.00.16k, Ablation of Lung Tumors

MA11.052e, Ablation of Lung Tumors

11.00.16j, Ablation of Lung Tumors

MA11.052f, Ablation of Lung Tumors